This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Haemorrhagic disease of the newborn and antiepileptic drugs

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • mortality associated with neonatal bleeding from vitamin K1 deficiency is over 30%

  • exposure to enzyme-inducing drugs increases the risk of haemorrhagic disease of the newborn. This includes exposure to antiepileptic drugs such as carbamazepine, phenytoin and phenobarbitone (1)

  • it is recommended that infants with prenatal exposure to antiepileptic drugs should receive 1mg vitamin K intramuscularly at birth (1)

Reference:

  • (1) Prescriber (2001), 12 (18), 30-36.

Related pages

Create an account to add page annotations

Create a free account

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.